Design, synthesis and evaluation of some new 4-aminopyridine derivatives in learning and memory.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2013-05-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2013.03.026PMID 23562059
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and evaluation of some new 4-aminopyridine derivatives as a potent antiamnesic and cognition enhancing drugs

  2012cited by this paper
• Synthesis, cytotoxic evaluation and in silico pharmacokinetic prediction of some benzo[a]phenazine-5-sulfonic acid derivatives.

  2009cited by this paper
• 4-Aminopyridine derivatives with anticholinesterase and antiamnesic activity.

  2008cited by this paper
• Post-training intracranial self-stimulation facilitates a hippocampus-dependent task.

  2005cited by this paper
• Reversal of scopolamine‐induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor

  2005cited by this paper
• Evaluation of cholinergic markers in Alzheimer's disease and in a model of cholinergic deficit.

  2005cited by this paper
• p-Aminobenzoic acid derivatives as acetylcholinesterase inhibitors.

  2005cited by this paper
• Noradrenergic action in prefrontal cortex in the late stage of memory consolidation.

  2004cited by this paper
• Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

  2004cited by this paper
• Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

  2004cited by this paper
• Velnacrine for Alzheimer's disease.

  2004cited by this paper
• Synthesis, anticholinesterase activity and structure-activity relationships of m-Aminobenzoic acid derivatives.

  2003cited by this paper
• beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies.

  2003cited by this paper
• Current drug targets for Alzheimer's disease treatment

  2002cited by this paper
• Is anti-cholinesterase therapy of Alzheimer’s disease delaying progression?

  2001cited by this paper
• 4-Aminopyridine derivatives with antiamnesic activity.

  2000cited by this paper
• Hepatotoxicity of tacrine: occurrence of membrane fluidity alterations without involvement of lipid peroxidation.

  2000cited by this paper
• The hippocampus, consolidation and on-line memory.

  1998cited by this paper
• 4-aminopyridine in the treatment of patients with multiple sclerosis. Long-term efficacy and safety.

  1994cited by this paper
• 4-Aminopyridine in the Treatment of Patients With Multiple Sclerosis: Long-term Efficacy and Safety

  1994cited by this paper
• Characterization of 4-aminopyridine in overdose.

  1994cited by this paper
• Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core.

  1994cited by this paper
• Mechanism of action of cholinesterase inhibitors in Alzheimer's disease

  1993cited by this paper
• Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice.

  1992cited by this paper
• Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock

  1990cited by this paper
• Hypothalamic afferents to the dorsal dentate gyrus contain acetylcholinesterase.

  1983cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• Treatment with oral 4‐aminopyridine in disorders of neuromuscular transmission

  1981cited by this paper
• CHANGES IN BRAIN CHOLINESTERASES IN SENILE DEMENTIA OF ALZHEIMER TYPE

  1978cited by this paper
• Selective loss of central cholinergic neurons in Alzheimer's disease.

  1976cited by this paper
• Choline acetyltransferase inhibitors. Styrylpyridine analogs with nitrogen-atom modifications.

  1971cited by this paper
• The Determination of Enzyme Dissociation Constants

  1934cited by this paper
• Biological Crystallography Structures of Recombinant Native and E202q Mutant Human Acetylcholinesterase Complexed with the Snake-venom Toxin Fasciculin-ii

  year unknowncited by this paper

• Scaffold Hopping Strategy Toward Novel Pyrazolo[3,4-d]pyrimidine-Based Thiazole Frameworks as Potential Cholinesterase Inhibitors for Treating Alzheimer’s Disease: Insight into In Vitro and In Silico Approaches

  2026cites this paper
• Structure-Guided Design, Synthesis, and Biological Evaluation of Peripheral Anionic Site Selective and Brain Permeable Novel Oxadiazole-Piperazine Conjugates against Alzheimer’s Disease with Antioxidant Potential

  2024cites this paper
• Design and development of benzyl piperazine linked 5-phenyl-1,2,4-triazole-3-thione conjugates as potential agents to combat Alzheimer's disease.

  2023cites this paper
• Discovery of novel dual acetylcholinesterase and butyrylcholinesterase inhibitors using machine learning and structure-based drug design

  2023cites this paper
• Conjugates of desferrioxamine and aromatic amines improve markers of iron-dependent neurotoxicity

  2021cites this paper
• Cholinesterase as a Target for Drug Development in Alzheimer's Disease.

  2020cites this paper
• Targeting Enzymes for Pharmaceutical Development: Methods and Protocols

  2020cites this paper
• Critical evaluation of current Alzheimer's drug discovery (2018-19) & futuristic Alzheimer drug model approach.

  2019cites this paper
• Design and development of novel p-aminobenzoic acid derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's disease.

  2019cites this paper
• Design and development of 1,3,4-oxadiazole derivatives as potential inhibitors of acetylcholinesterase to ameliorate scopolamine-induced cognitive dysfunctions.

  2019cites this paper
• Design, synthesis, and evaluation of novel N-(4-phenoxybenzyl)aniline derivatives targeting acetylcholinesterase, β-amyloid aggregation and oxidative stress to treat Alzheimer's disease.

  2019cites this paper
• Probing the in-air growth of large area of 3D functional structures into a 2D supramolecular nanoporous network.

  2018cites this paper
• IN-VITRO EVALUATION AND MOLECULAR DOCKING STUDIES OF SOME SCHIFF BASES AS CHOLINESTERASE INHIBITOR

  2015cites this paper
• Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 2014

  2014cites this paper
• Synthesis, evaluation and molecular dynamics study of some new 4-aminopyridine semicarbazones as an antiamnesic and cognition enhancing agents.

  2013cites this paper